Understanding GLP-1s — and the community around them

What are GLP-1 medications?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed to treat type 2 diabetes. They mimic a naturally occurring hormone in your body that regulates blood sugar, slows the emptying of your stomach, and sends fullness signals to your brain. In recent years, their powerful effect on appetite and weight management has made them a widely prescribed tool for people working toward better health.

Where they came from

The story of GLP-1s begins with an unlikely source — the venom of the Gila monster, a lizard native to the American Southwest. In the 1990s, scientists discovered that a protein in that venom behaved much like human GLP-1 but lasted far longer in the body. That discovery led to the first GLP-1 medication, exenatide, approved in 2005. Newer generations like semaglutide and tirzepatide have since become more effective and longer-lasting.

How they actually help with weight loss

GLP-1s support weight loss through several overlapping mechanisms:

• Reduced appetite — they act on brain regions that regulate hunger, helping you feel less driven to eat.
• Increased fullness — by slowing stomach emptying, you feel satisfied from smaller portions.
• Better blood sugar control — more stable blood sugar means fewer spikes and crashes that trigger cravings.
• Shifts in food preference — many people naturally gravitate toward less sweet, less fatty foods over time.

Benefits beyond the scale

Research suggests GLP-1s may offer benefits beyond weight loss, including improvements in cardiovascular health markers, kidney function, and inflammation. Some studies are exploring effects on addiction behaviors and sleep apnea. These are promising signals — and a reminder that these medications touch many systems in the body.